Ceftolozane

Records for this ingredient, by country (identity only).

ATC J01DI54 · 9 markets · 10 records

Ceftolozane 9 markets · 10 records Forms

Filters

MarketUS 1 GB 1 CA 1 AU 1 ES 1 TW 1 HK 1 EU 1

Kind

Strength

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

Combination products containing this ingredient

1,000 mg/10 mLinjection CombinationCeftolozane 1,000 mg/10 mL + Tazobactam 500 mg/10 mLZERBAXA

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

Combination products containing this ingredient

1,000 mg per mL / per unit basis not statedinjection CombinationCeftolozane 1,000 mg + Tazobactam 500 mgZerbaxa 1g/0.5g powder for concentrate for solution for infusion vials

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

1,000 mgpowder CombinationCeftolozane 1,000 mg + Tazobactam 500 mgZERBAXA

AU 1 records · 0 shown of 0 Source TGA CMI repository (consumer medic · Data as of live · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ZERBAXA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

Combination products containing this ingredient

1,000 mg per mL / per unit basis not statedinjection CombinationCeftolozane 1,000 mg + Tazobactam 500 mgZERBAXA

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Zerbaxa for Injection ×1諾倍適乾粉注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ZERBAXA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/0.5G ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ZERBAXA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	TW	HK	EU
1,000 mgRecorded as: 1 g per mL / per unit basis not stated cannot compare Combination Ceftolozane 1,000 mg + Tazobactam 500 mg injection	not recorded	Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials	not recorded	not recorded	ZERBAXA	not recorded	not recorded	not recorded
1,000 mg/10 mLRecorded as: 1 g/10 mL Combination Ceftolozane 1,000 mg/10 mL + Tazobactam 500 mg/10 mL injection	ZERBAXA	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
1,000 mgRecorded as: 1 g Combination Ceftolozane 1,000 mg + Tazobactam 500 mg powder	not recorded	not recorded	ZERBAXA	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed Combination Ceftolozane + Tazobactam unknown	not recorded	not recorded	not recorded	ZERBAXA	not recorded	not recorded	ZERBAXA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/0.5G	ZERBAXA
not disclosed Combination Ceftolozane + Tazobactam injection	not recorded	not recorded	not recorded	not recorded	not recorded	Zerbaxa for 諾倍適乾粉注射劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in GB · CA · ES and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en GB · CA · ES que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 GB · CA · ES 有记录（未在本表显示）。另有 2 個規格/劑型僅在 GB · CA · ES 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.